Roberts Eric W reported grant involving 180,000 derivative units of CalciMedica, Inc. at $0.00 for $0 on Nov 3, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
CHIEF BUSINESS OFFICER
CHIEF BUSINESS OFFICER
Filed Nov 5, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
180,000Employee Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
180,000Direct
Trade date
Nov 3, 2026Grant
Filed
Nov 5, 2026, 4:15 PM ET2-day reporting delay
Accession
0001576244-26-000006Code A · Transaction 393482
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

CALC price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CALC · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +8.8%1w ago −11%1d ago −4.8%
Returns since7d −17%30d90d180d1y

Footnotes in full

F1: Beginning September 24, 2026, 1/48th of the shares subject to the option shall vest in equal monthly installments over a four year period.